It comes diown to the CR and (subject to timings) the CR depends...

It comes diown to the CR and (subject to timings) the CR depends on what we have not yet seen.

The point here is whilst the madding crowd may be correct in terms of an eventual outcome (may be) a lot of the discussion here regards marginal or circumstantial considerations that while they may provide a basis for a view, they are not empirical evidence.

That simply means that we don't definitively know, furthermore, that the reliance on such an approach is flawed and it's promotion is as concerning as the behaviours critiqued.

it's likely fair to say that the enthusiasm held this time last year was also not based on empirical evidence, but clearly the potential contemporaneous upside reward outweighs prevailing downside risk.

Given the impending liquidity crisis and the SP resilience, one must assume that either investors are indifferent, perceive merrit remains in the upside argument, or see a benefit for being a holder beyond an insolvency point.

You have to remember not everyone looks through the same lens. Some are as you say more 'equal' than others.

I think this should get interesting by the AGM.

An AGM scenario with no attempted CR or liquidity solution discussed and no announcemen re finals or a progress update would more likely lead me to more closely align to your thinking.... I can't see that transpiring, but we're it to I'd be thinking incompetence or much worse, malfeasance.

ie if historical testing is ignored and say dengue fefer is championed, raise sought I'd be beyond perplexed.

For now we wait results and response. If the narrative is reasonable I would not be surprised if CR is achieved. If CR is achieved, it will likely mean an identified niche fior the technology, and say (guessing) sponsorship of further testing. As indicated, it would appear a longer test window may better illustrate benefit. Ph 2c? / other ?

Absolute wild card might be an offer. As they say no news is good news.

I can understand why people without tolerance for downside risk would jump out prior to the AGM. It's not atypical of thiss situations.

Of course for every shsre sold at these levels, there has had to be va buyer. Given the perception of risk discussed here and the stability of the price t could actually be looked at aa a strong case for the bid surely.?

Either the iffer knows or expect they know something different than is voiced here, or posdibly holders are waiting for more empirical evidence to rely upon..